Skip to main content

Peer Review reports

From: Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients

Original Submission
18 Jul 2021 Submitted Original manuscript
17 Aug 2021 Reviewed Reviewer Report
19 Sep 2021 Reviewed Reviewer Report - Vassilis Georgoulias
12 Oct 2021 Author responded Author comments - Chung-Yu Chen
Resubmission - Version 2
12 Oct 2021 Submitted Manuscript version 2
13 Oct 2021 Author responded Author comments - Chung-Yu Chen
Resubmission - Version 3
13 Oct 2021 Submitted Manuscript version 3
Publishing
25 Oct 2021 Editorially accepted
15 Nov 2021 Article published 10.1186/s12885-021-08920-3

You can find further information about peer review here.

Back to article page